おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
Dynomics
About
Molecules to restore heart function.
- San Mateo,California,United States
- 1 - 10
Details
- Last Funding Type
- Pre-seed
- Last Funding Money Raised
- $500K
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Dynomics Inc.
We target therapeutics to human heart function, taking a precision approach to drug development and capturing the adult heart clinical phenotype. This is powered by our scalable, authentic and predictive discovery engine - HeartDyno. HeartDyno is built with engineered human cardiac organoids, scalably deployed to drive a multi-omics data-driven approach. It rapidly uncovers novel therapeutic targets and candidates that offer superior efficacy and safety profiles in humans. Dynomics’ approach is validated through collaboration with top pharmaceutical companies, top-tier scientific publications, and we are progressing assets targeting heart failure, affecting 4% of the US population and where current treatments provide a 50% 5-year survival rate.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 17, 2020 | Pre-seed | $500K | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Boost VC
|
— | Pre-seed |
Employee Profiles
